The Brighterside of News on MSN
New drug combo cuts risk of death for men with prostate cancer by 40%
Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive ...
A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...
Adding the drug enzalutamide to standard hormone therapy reduced deaths by more than 40% in men with recurrent prostate ...
A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...
A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, ...
A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer ...
Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...
Some people with psoriatic arthritis (PsA) may have a disease that is difficult to manage (D2M) or does not respond to ...
Although findings from a large retrospective study supports these positive effects of taking a GLP-1, it’s unclear whether ...
Bristol-Myers Squibb Company (NYSE:BMY) is one of the best NYSE stocks to buy and hold for the next decade. On October 27, Bristol Myers Squibb announced new Week 52 data from its pivotal Phase 3 ...
News Medical on MSN
New evidence-based points to consider and consensus definitions for people with psoriatic arthritis
Some people with psoriatic arthritis (PsA) may have disease that is difficult to manage (D2M) or does not respond to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback